Prognostic factors in advanced biliary tract cancer treated with first-line chemotherapy with cisplatin and gemcitabine

被引：0
|
作者：
Peixoto, Renata D'Alpino [1 ]
Renouf, Daniel John [1 ]
Lim, Howard John [1 ]
机构：
[1] BC Canc Agcy, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.350
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
350
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin chemotherapy: retrospective analysis of 142 patients
    Engin, H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] Pembrolizumab in combination with first-line chemotherapy with gemcitabine-cisplatin for advanced biliary tract cancer
    d'Abrigeon, Constance
    Cindy, Neuzillet
    BULLETIN DU CANCER, 2024, 111 (06) : 541 - 542
  • [3] EFFICACY AND SAFETY OF GEMCITABINE PLUS CISPLATIN AS FIRST-LINE CHEMOTHERAPY FOR ADVANCED BILIARY TRACT CANCER
    Oka, Y.
    Todaka, A.
    Fukutomi, A.
    Tsushima, T.
    Yokota, T.
    Machida, N.
    Yamazaki, K.
    Onozawa, Y.
    Boku, N.
    Yasui, H.
    ANNALS OF ONCOLOGY, 2013, 24 : 44 - 44
  • [4] Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients
    Bum Jun Kim
    Jaewon Hyung
    Changhoon Yoo
    Kyu-pyo Kim
    Seong-Joon Park
    Sang Soo Lee
    Do Hyun Park
    Tae Jun Song
    Dong Wan Seo
    Sung Koo Lee
    Myung-Hwan Kim
    Jin-hong Park
    Hyungwoo Cho
    Baek-Yeol Ryoo
    Heung-Moon Chang
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 209 - 215
  • [5] Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients
    Kim, Bum Jun
    Hyung, Jaewon
    Yoo, Changhoon
    Kim, Kyu-pyo
    Park, Seong-Joon
    Lee, Sang Soo
    Park, Do Hyun
    Song, Tae Jun
    Seo, Dong Wan
    Lee, Sung Koo
    Kim, Myung-Hwan
    Park, Jin-hong
    Cho, Hyungwoo
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (01) : 209 - 215
  • [6] Predictive factors of outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
    Suzuki, Y.
    Kan, M.
    Kimura, G.
    Umemoto, K.
    Watanabe, K.
    Sasaki, M.
    Takahashi, H.
    Hashimoto, Y.
    Imaoka, H.
    Ohno, I.
    Mitsunaga, S.
    Ikeda, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy
    Kim, Hyera
    Kim, Seung Tae
    Yoo, Kwai Han
    Hong, Jung Yong
    Park, Young Suk
    Lim, Ho Yeong
    Park, Joon Oh
    IN VIVO, 2021, 35 (01): : 499 - 505
  • [8] Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer
    Park, Kwonoh
    Kim, Kyu-pyo
    Park, Seongjoon
    Chang, Heung-Moon
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (01) : 13 - 20
  • [9] Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
    Suzuki, Yuko
    Kan, Motoyasu
    Kimura, Gen
    Umemoto, Kumiko
    Watanabe, Kazuo
    Sasaki, Mitsuhito
    Takahashi, Hideaki
    Hashimoto, Yusuke
    Imaoka, Hiroshi
    Ohno, Izumi
    Mitsunaga, Shuichi
    Ikeda, Masafumi
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (03) : 281 - 290
  • [10] Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
    Yuko Suzuki
    Motoyasu Kan
    Gen Kimura
    Kumiko Umemoto
    Kazuo Watanabe
    Mitsuhito Sasaki
    Hideaki Takahashi
    Yusuke Hashimoto
    Hiroshi Imaoka
    Izumi Ohno
    Shuichi Mitsunaga
    Masafumi Ikeda
    Journal of Gastroenterology, 2019, 54 : 281 - 290
12345